In the face of mounting drug scandals and perjured congressional testimony, a key House Democrat, Rep. Bart Stupak (D-MI), told the Associated Press that FDA Commissioner Andrew von Eschenbach should step down. Stupak sites a “total lack of leadership” as it becomes plainly apparent that the FDA is unable to protect Americans from the dangers of drugs or ensure a safe food supply. The most troubling issue regarding FDA leadership is that many of these issues are due to gross negligence or taking the side of drug companies at the expense of human health.
Read More: Andrew von Eschenbach,
antibiotics,
Bayer,
China,
deaths,
drug scandals,
FDA,
Heparin,
Ketek,
liver failure,
Trasylol
The sparks flew on Capital Hill last week. During grilling of FDA executives Rep. John Dingell (D., Mich.), the chairman of the House Commerce and Energy Committee, said "Our citizens can no longer trust that their food, drugs or medical devices are safe when the FDA says they are."
Read More: China,
Congress,
FDA,
Heparin,
Trasylol
Last week the FDA refused to disclose to Congress the names of Chinese drug companies in the supply chain that provided the tainted Heparin which killed Americans, as reported by the Wall Street Journal. The net effect is that the FDA is intentionally acting to cover up China’s crimes against Americans...
Read More: China,
FDA,
Heparin